Works by Nogami, Naoyuki

Results: 40

Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015.

Published in:

2016

By:

Toshiyuki Kozuki;
Naoyuki Nogami;
Hiromoto Kitajima;
Shunichiro Iwasawa;
Emiko Sakaida;
Yuichi Takiguchi;
Satoshi Ikeda;
Masahiro Yoshida;
Terufumi Kato;
Shingo Miyamoto;
Kentaro Sakamaki;
Tetsu Shinkai;
Koshiro Watanabe;
Kozuki, Toshiyuki;
Nogami, Naoyuki;
Kitajima, Hiromoto;
Iwasawa, Shunichiro;
Sakaida, Emiko;
Takiguchi, Yuichi;
Ikeda, Satoshi

Publication type:

journal article

A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL).

Published in:

Japanese Journal of Clinical Oncology, 2024, v. 54, n. 7, p. 805, doi. 10.1093/jjco/hyae044

By:

Nogami, Naoyuki;
Kubo, Toshio;
Bessho, Akihiro;
Sakugawa, Makoto;
Ikeo, Satoshi;
Yokoyama, Toshihide;
Seki, Nobuhiko;
Ochiai, Ryosuke;
Fujimoto, Nobukazu;
Murakami, Shuji;
Kaira, Kyoichi;
Harada, Toshiyuki;
Kishino, Daizo;
Takiguchi, Yuichi;
Shimokawa, Tsuneo;
Kiura, Katsuyuki;
Yamashita, Natsumi;
Okamoto, Hiroaki

Publication type:

Article

Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404.

Published in:

Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1269, doi. 10.1093/jjco/hyab084

By:

Ninomiya, Takashi;
Nogami, Naoyuki;
Kozuki, Toshiyuki;
Harada, Daijiro;
Kubo, Toshio;
Ohashi, Kadoaki;
Ichihara, Eiki;
Kuyama, Shoichi;
Kudo, Kenichiro;
Bessho, Akihiro;
Sakugawa, Makoto;
Fujimoto, Nobukazu;
Aoe, Keisuke;
Minami, Daisuke;
Sugimoto, Keisuke;
Ochi, Nobuaki;
Takigawa, Nagio;
Hotta, Katsuyuki;
Maeda, Yoshinobu;
Kiura, Katsuyuki

Publication type:

Article

Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

Published in:

Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157

By:

Saka, Hideo;
Nishio, Makoto;
Hida, Toyoaki;
Nakagawa, Kazuhiko;
Sakai, Hiroshi;
Nogami, Naoyuki;
Atagi, Shinji;
Takahashi, Toshiaki;
Horinouchi, Hidehito;
Takenoyama, Mitsuhiro;
Katakami, Nobuyuki;
Tanaka, Hiroshi;
Takeda, Koji;
Satouchi, Miyako;
Isobe, Hiroshi;
Maemondo, Makoto;
Goto, Koichi;
Hirashima, Tomonori;
Minato, Koichi;
Yada, Nobumichi

Publication type:

Article

Osimertinib versus standard-of-care EGFR-TKI as first-line treatment for EGFRm advanced NSCLC: FLAURA Japanese subset.

Published in:

Japanese Journal of Clinical Oncology, 2019, v. 49, n. 1, p. 29, doi. 10.1093/jjco/hyy179

By:

Ohe, Yuichiro;
Imamura, Fumio;
Nogami, Naoyuki;
Okamoto, Isamu;
Kurata, Takayasu;
Kato, Terufumi;
Sugawara, Shunichi;
Ramalingam, Suresh S;
Uchida, Hirohiko;
Hodge, Rachel;
Vowler, Sarah L;
Walding, Andrew;
Nakagawa, Kazuhiko

Publication type:

Article

A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.

Published in:

2021

By:

Creelan, Benjamin C.;
Yeh, Tammie C.;
Kim, Sang-We;
Nogami, Naoyuki;
Kim, Dong-Wan;
Chow, Laura Q. M.;
Kanda, Shintaro;
Taylor, Rosemary;
Tang, Weifeng;
Tang, Mei;
Angell, Helen K.;
Roudier, Martine P.;
Marotti, Marcelo;
Gibbons, Don L.

Publication type:

journal article

Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

Published in:

2013

By:

Okamoto, Isamu;
Aoe, Keisuke;
Kato, Terufumi;
Hosomi, Yukio;
Yokoyama, Akira;
Imamura, Fumio;
Kiura, Katsuyuki;
Hirashima, Tomonori;
Nishio, Makoto;
Nogami, Naoyuki;
Okamoto, Hiroaki;
Saka, Hideo;
Yamamoto, Nobuyuki;
Yoshizuka, Naoto;
Sekiguchi, Risa;
Kiyosawa, Kazuhiro;
Nakagawa, Kazuhiko;
Tamura, Tomohide

Publication type:

Journal Article

Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

Published in:

2013

By:

Okamoto, Isamu;
Aoe, Keisuke;
Kato, Terufumi;
Hosomi, Yukio;
Yokoyama, Akira;
Imamura, Fumio;
Kiura, Katsuyuki;
Hirashima, Tomonori;
Nishio, Makoto;
Nogami, Naoyuki;
Okamoto, Hiroaki;
Saka, Hideo;
Yamamoto, Nobuyuki;
Yoshizuka, Naoto;
Sekiguchi, Risa;
Kiyosawa, Kazuhiro;
Nakagawa, Kazuhiko;
Tamura, Tomohide

Publication type:

Journal Article

Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

Published in:

Investigational New Drugs, 2013, v. 31, n. 5, p. 1275, doi. 10.1007/s10637-013-9941-z

By:

Okamoto, Isamu;
Aoe, Keisuke;
Kato, Terufumi;
Hosomi, Yukio;
Yokoyama, Akira;
Imamura, Fumio;
Kiura, Katsuyuki;
Hirashima, Tomonori;
Nishio, Makoto;
Nogami, Naoyuki;
Okamoto, Hiroaki;
Saka, Hideo;
Yamamoto, Nobuyuki;
Yoshizuka, Naoto;
Sekiguchi, Risa;
Kiyosawa, Kazuhiro;
Nakagawa, Kazuhiko;
Tamura, Tomohide

Publication type:

Article

Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

Published in:

2013

By:

Okamoto, Isamu;
Aoe, Keisuke;
Kato, Terufumi;
Hosomi, Yukio;
Yokoyama, Akira;
Imamura, Fumio;
Kiura, Katsuyuki;
Hirashima, Tomonori;
Nishio, Makoto;
Nogami, Naoyuki;
Okamoto, Hiroaki;
Saka, Hideo;
Yamamoto, Nobuyuki;
Yoshizuka, Naoto;
Sekiguchi, Risa;
Kiyosawa, Kazuhiro;
Nakagawa, Kazuhiko;
Tamura, Tomohide

Publication type:

Correction Notice

Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer.

Published in:

2012

By:

Okamoto, Isamu;
Yamamoto, Nobuyuki;
Kubota, Kaoru;
Ohe, Yuichiro;
Nogami, Naoyuki;
Murakami, Haruyasu;
Yamaya, Hidetoshi;
Ono, Katsuhiro;
Nakagawa, Kazuhiko

Publication type:

Journal Article

Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer.

Published in:

Investigational New Drugs, 2012, v. 30, n. 3, p. 1132, doi. 10.1007/s10637-011-9674-9

By:

Okamoto, Isamu;
Yamamoto, Nobuyuki;
Kubota, Kaoru;
Ohe, Yuichiro;
Nogami, Naoyuki;
Murakami, Haruyasu;
Yamaya, Hidetoshi;
Ono, Katsuhiro;
Nakagawa, Kazuhiko

Publication type:

Article

Clinical features and treatment of epidermal growth factor inhibitor‐related late‐phase papulopustular rash.

Published in:

Journal of Dermatology (John Wiley & Sons, Inc.), 2020, v. 47, n. 2, p. 121, doi. 10.1111/1346-8138.15170

By:

Tohyama, Mikiko;
Hamada, Makoto;
Harada, Daijiro;
Kozuki, Toshiyuki;
Nogami, Naoyuki;
Monden, Nobuya;
Kajiwara, Takeshi;
Nishina, Tomohiro

Publication type:

Article

Chemoradiotherapy in Elderly Patients With Non-Small-Cell Lung Cancer: Long-Term Follow-Up of a Randomized Trial (JCOG0301).

Published in:

2018

By:

Shinji Atagi;
Junki Mizusawa;
Satoshi Ishikura;
Toshiaki Takahashi;
Hiroaki Okamoto;
Hiroshi Tanaka;
Koichi Goto;
Kazuhiko Nakagawa;
Masao Harada;
Yuichiro Takeda;
Naoyuki Nogami;
Yuka Fujita;
Takashi Kasai;
Kazuma Kishi;
Toshiyuki Sawa;
Koji Takeda;
Keisuke Tomii;
Miyako Satouchi;
Takashi Seto;
Yuichiro Ohe

Publication type:

journal article

Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non--Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol.

Published in:

Clinical Lung Cancer, 2016, v. 17, n. 1, p. 75, doi. 10.1016/j.cllc.2015.08.004

By:

Katsuyuki Hotta;
Jiichiro Sasaki;
Sho Saeki;
Nagio Takigawa;
Kuniaki Katsui;
Koichi Takayama;
Naoyuki Nogami;
Yoshiyuki Shioyama;
Akihiro Bessho;
Junji Kishimoto;
Mitsune Tanimoto;
Katsuyuki Kiura;
Yukito Ichinose

Publication type:

Article

Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non-Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol.

Published in:

2016

By:

Hotta, Katsuyuki;
Sasaki, Jiichiro;
Saeki, Sho;
Takigawa, Nagio;
Katsui, Kuniaki;
Takayama, Koichi;
Nogami, Naoyuki;
Shioyama, Yoshiyuki;
Bessho, Akihiro;
Kishimoto, Junji;
Tanimoto, Mitsune;
Kiura, Katsuyuki;
Ichinose, Yukito

Publication type:

journal article

Early response of bone metastases can predict tumor response in patients with non-small-cell lung cancer with bone metastases in the treatment with nivolumab.

Published in:

Oncology Letters, 2020, v. 20, n. 3, p. 2977, doi. 10.3892/ol.2020.11856

By:

Nakata, Eiji;
Sugihara, Shinsuke;
Sugawara, Yoshifumi;
Kozuki, Toshiyuki;
Harada, Daijiro;
Nogami, Naoyuki;
Nakahara, Ryuichi;
Furumatsu, Takayuki;
Tetsunaga, Tomonori;
Kunisada, Toshiyuki;
Ozaki, Toshifumi

Publication type:

Article

Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic Oncology Research Group (TORG) 1017.

Published in:

Molecular & Clinical Oncology, 2019, v. 11, n. 4, p. 349, doi. 10.3892/mco.2019.1903

By:

Nakahara, Yoshiro;
Hosomi, Yukio;
Shibuya, Masahiko;
Mitsufuji, Hisashi;
Katagiri, Masato;
Naoki, Katsuhiko;
Soejima, Kenzo;
Nogami, Naoyuki;
Nagase, Seisuke;
Nishikawa, Masanori;
Minato, Koichi;
Takiguchi, Yuichi;
Seki, Nobuhiko;
Yamada, Kouzo;
Seto, Takashi;
Okamoto, Hiroaki

Publication type:

Article

Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial.

Published in:

2016

By:

Takeda, Masayuki;
Yamanaka, Takeharu;
Seto, Takashi;
Hayashi, Hidetoshi;
Azuma, Koichi;
Okada, Morihito;
Sugawara, Shunichi;
Daga, Haruko;
Hirashima, Tomonori;
Yonesaka, Kimio;
Urata, Yoshiko;
Murakami, Haruyasu;
Saito, Haruhiro;
Kubo, Akihito;
Sawa, Toshiyuki;
Miyahara, Eiji;
Nogami, Naoyuki;
Nakagawa, Kazuhiko;
Nakanishi, Yoichi;
Okamoto, Isamu

Publication type:

journal article

Pembrolizumab plus pemetrexed‐platinum for metastatic nonsquamous non–small‐cell lung cancer: KEYNOTE‐189 Japan Study.

Published in:

Cancer Science, 2021, v. 112, n. 8, p. 3255, doi. 10.1111/cas.14980

By:

Horinouchi, Hidehito;
Nogami, Naoyuki;
Saka, Hideo;
Nishio, Makoto;
Tokito, Takaaki;
Takahashi, Toshiaki;
Kasahara, Kazuo;
Hattori, Yoshihiro;
Ichihara, Eiki;
Adachi, Noriaki;
Noguchi, Kazuo;
Souza, Fabricio;
Kurata, Takayasu

Publication type:

Article

Lorlatinib in previously treated anaplastic lymphoma kinase‐rearranged non–small cell lung cancer: Japanese subgroup analysis of a global study.

Published in:

Cancer Science, 2020, v. 111, n. 10, p. 3726, doi. 10.1111/cas.14576

By:

Seto, Takashi;
Hayashi, Hidetoshi;
Satouchi, Miyako;
Goto, Yasushi;
Niho, Seiji;
Nogami, Naoyuki;
Hida, Toyoaki;
Takahashi, Toshiaki;
Sakakibara‐Konishi, Jun;
Morise, Masahiro;
Nagasawa, Takashi;
Suzuki, Mie;
Ohkura, Masayuki;
Fukuhara, Kei;
Thurm, Holger;
Peltz, Gerson;
Nishio, Makoto

Publication type:

Article

Safety and efficacy of first‐line dacomitinib in Japanese patients with advanced non‐small cell lung cancer.

Published in:

Cancer Science, 2020, v. 111, n. 5, p. 1724, doi. 10.1111/cas.14384

By:

Nishio, Makoto;
Kato, Terufumi;
Niho, Seiji;
Yamamoto, Noboru;
Takahashi, Toshiaki;
Nogami, Naoyuki;
Kaneda, Hiroyasu;
Fujita, Yuka;
Wilner, Keith;
Yoshida, Mizuki;
Isozaki, Mitsuhiro;
Wada, Shinsuke;
Tsuji, Fumito;
Nakagawa, Kazuhiko

Publication type:

Article

Osimertinib in patients with epidermal growth factor receptor T790M advanced non‐small cell lung cancer selected using cytology samples.

Published in:

Cancer Science, 2018, v. 109, n. 4, p. 1177, doi. 10.1111/cas.13511

By:

Kiura, Katsuyuki;
Yoh, Kiyotaka;
Katakami, Nobuyuki;
Nogami, Naoyuki;
Kasahara, Kazuo;
Takahashi, Toshiaki;
Okamoto, Isamu;
Cantarini, Mireille;
Hodge, Rachel;
Uchida, Hirohiko

Publication type:

Article

Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.

Published in:

Cancer Science, 2017, v. 108, n. 5, p. 1000, doi. 10.1111/cas.13225

By:

Hida, Toyoaki;
Nishio, Makoto;
Nogami, Naoyuki;
Ohe, Yuichiro;
Nokihara, Hiroshi;
Sakai, Hiroshi;
Satouchi, Miyako;
Nakagawa, Kazuhiko;
Takenoyama, Mitsuhiro;
Isobe, Hiroshi;
Fujita, Shiro;
Tanaka, Hiroshi;
Minato, Koichi;
Takahashi, Toshiaki;
Maemondo, Makoto;
Takeda, Koji;
Saka, Hideo;
Goto, Koichi;
Atagi, Shinji;
Hirashima, Tomonori

Publication type:

Article

Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experience.

Published in:

2016

By:

Kudo, Kenichiro;
Hotta, Katsuyuki;
Bessho, Akihiro;
Nogami, Naoyuki;
Kozuki, Toshiyuki;
Kuyama, Shoichi;
Inoue, Koji;
Harita, Shingo;
Okada, Toshiaki;
Gemba, Kenichi;
Fujii, Masanori;
Takigawa, Nagio;
Oda, Naohiro;
Tanimoto, Mitsune;
Kiura, Katsuyuki

Publication type:

journal article

Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 943, doi. 10.1007/s00280-014-2425-9

By:

Kato, Yuka;
Hotta, Katsuyuki;
Takigawa, Nagio;
Nogami, Naoyuki;
Kozuki, Toshiyuki;
Sato, Akiko;
Ichihara, Eiki;
Kudo, Kenichiro;
Oze, Isao;
Tabata, Masahiro;
Shinkai, Tetsu;
Tanimoto, Mitsune;
Kiura, Katsuyuki

Publication type:

Article

Three‐year follow‐up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non‐small cell lung cancer: Pooled analysis of ONO‐4538‐05 and ONO‐4538‐06 studies.

Published in:

Cancer Medicine, 2019, v. 8, n. 11, p. 5183, doi. 10.1002/cam4.2411

By:

Horinouchi, Hidehito;
Nishio, Makoto;
Hida, Toyoaki;
Nakagawa, Kazuhiko;
Sakai, Hiroshi;
Nogami, Naoyuki;
Atagi, Shinji;
Takahashi, Toshiaki;
Saka, Hideo;
Takenoyama, Mitsuhiro;
Katakami, Nobuyuki;
Tanaka, Hiroshi;
Takeda, Koji;
Satouchi, Miyako;
Isobe, Hiroshi;
Maemondo, Makoto;
Goto, Koichi;
Hirashima, Tomonori;
Minato, Koichi;
Sumiyoshi, Naoki

Publication type:

Article

Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment.

Published in:

2012

By:

Hamamoto Y;
Kataoka M;
Yamashita M;
Nogami N;
Sugawara Y;
Kozuki T;
Sawada S;
Suehisa H;
Shinohara S;
Nakajima N;
Shinkai T;
Hamamoto, Yasushi;
Kataoka, Masaaki;
Yamashita, Motohiro;
Nogami, Naoyuki;
Sugawara, Yoshifumi;
Kozuki, Toshiyuki;
Sawada, Shigeki;
Suehisa, Hiroshi;
Shinohara, Syuichi

Publication type:

journal article

Factors affecting the local control of stereotactic body radiotherapy for lung tumors including primary lung cancer and metastatic lung tumors.

Published in:

Japanese Journal of Radiology, 2012, v. 30, n. 5, p. 430, doi. 10.1007/s11604-012-0071-x

By:

Hamamoto, Yasushi;
Kataoka, Masaaki;
Yamashita, Motohiro;
Nogami, Naoyuki;
Sugawara, Yoshifumi;
Kozuki, Toshiyuki;
Sawada, Shigeki;
Suehisa, Hiroshi;
Shinohara, Syuichi;
Nakajima, Naomi;
Shinkai, Tetsu

Publication type:

Article

Factors affecting survival time after recurrence of non-small-cell lung cancer treated with concurrent chemoradiotherapy.

Published in:

Japanese Journal of Radiology, 2012, v. 30, n. 3, p. 249, doi. 10.1007/s11604-011-0040-9

By:

Hamamoto, Yasushi;
Kataoka, Masaaki;
Nogami, Naoyuki;
Kozuki, Toshiyuki;
Kato, Yuka;
Shinohara, Shuichi;
Shinkai, Tetsu

Publication type:

Article

5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study.

Published in:

BMC Pharmacology & Toxicology, 2020, v. 21, n. 1, p. N.PAG, doi. 10.1186/s40360-020-00445-y

By:

Matsui, Reiko;
Suzuki, Kenichi;
Takiguchi, Tomomi;
Nishio, Makoto;
Koike, Takeshi;
Hayashi, Toshinobu;
Seto, Takashi;
Kogure, Yuki;
Nogami, Naoyuki;
Fujiwara, Kimiko;
Kaneda, Hiroyasu;
Harada, Tomohiko;
Shimizu, Satoru;
Kimura, Masashi;
Kenmotsu, Hirotsugu;
Shimokawa, Mototsugu;
Goto, Koichi

Publication type:

Article

A phase I/II trial of weekly nab‐paclitaxel for pretreated non‐small‐cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement.

Published in:

Asia Pacific Journal of Clinical Oncology, 2019, v. 15, n. 4, p. 250, doi. 10.1111/ajco.13147

By:

Harada, Daijiro;
Kozuki, Toshiyuki;
Nogami, Naoyuki;
Bessho, Akihiro;
Hosokawa, Shinobu;
Fukamatsu, Nobuaki;
Hotta, Katsuyuki;
Ohashi, Kadoaki;
Kubo, Toshio;
Yoshioka, Hiroshige;
Yokoyama, Toshihide;
Sone, Naoyuki;
Kuyama, Shoichi;
Kudo, Kenichiro;
Yasugi, Masayuki;
Takigawa, Nagio;
Oze, Isao;
Kiura, Katsuyuki

Publication type:

Article

Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402.

Published in:

Acta Oncologica, 2012, v. 51, n. 6, p. 768, doi. 10.3109/0284186X.2011.648342

By:

Nogami, Naoyuki;
Hotta, Katsuyuki;
Segawa, Yoshihiko;
Takigawa, Nagio;
Hosokawa, Shinobu;
Oze, Isao;
Fujii, Masanori;
Ichihara, Eiki;
Shibayama, Takuo;
Tada, Atsuhiko;
Hamada, Noboru;
Uno, Masatoshi;
Tamaoki, Akihiko;
Kuyama, Shoichi;
Ikeda, Genyo;
Osawa, Masahiro;
Takata, Saburo;
Tabata, Masahiro;
Tanimoto, Mitsune;
Kiura, Katsuyuki

Publication type:

Article

Real-World EGFR T790M Testing in Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study in Japan.

Published in:

Oncology & Therapy, 2018, v. 6, n. 2, p. 203, doi. 10.1007/s40487-018-0064-8

By:

Seto, Takashi;
Nogami, Naoyuki;
Yamamoto, Nobuyuki;
Atagi, Shinji;
Tashiro, Naoki;
Yoshimura, Yoko;
Yabuki, Yutaka;
Saka, Hideo

Publication type:

Article

Preliminary evaluation of soluble IL-2 receptor and type III procollagen N-terminal aminopeptide in pleural fluid for differentiating tuberculous, carcinomatous and parapneumonic pleural effusions.

Published in:

Respirology, 2002, v. 7, n. 4, p. 311, doi. 10.1046/j.1440-1843.2002.01976.x

By:

HARITA, SHINGO;
NOGAMI, NAOYUKI;
KIKUCHI, TAKESHI;
KIBATA, MASAYOSHI

Publication type:

Article

Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer.

Published in:

Investigational New Drugs, 2024, v. 42, n. 1, p. 136, doi. 10.1007/s10637-023-01411-1

By:

Nogami, Naoyuki;
Tokito, Takaaki;
Zenke, Yoshitaka;
Satouchi, Miyako;
Seto, Takashi;
Saka, Hideo;
Ohtani, Junko;
Han, Shirong;
Noguchi, Kazuo;
Nishio, Makoto

Publication type:

Article

Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913.

Published in:

Investigational New Drugs, 2021, v. 39, n. 1, p. 202, doi. 10.1007/s10637-020-00985-4

By:

Nakahara, Yoshiro;
Shimokawa, Tsuneo;
Misumi, Yuki;
Nogami, Naoyuki;
Shinkai, Tetsu;
Seki, Nobuhiko;
Hosomi, Yukio;
Hida, Naoya;
Okamoto, Hiroaki

Publication type:

Article

A phase I/II trial of pemetrexed plus radiotherapy in elderly patients with locally advanced non-small cell lung cancer.

Published in:

Investigational New Drugs, 2018, v. 36, n. 4, p. 667, doi. 10.1007/s10637-018-0587-8

By:

Tamiya, Akihiro;
Morimoto, Masahiro;
Fukuda, Shoichi;
Naoki, Yoko;
Ibe, Tatsuya;
Okishio, Kyoichi;
Goto, Hideto;
Yoshii, Akihiro;
Kita, Toshiyuki;
Nogami, Naoyuki;
Fujita, Yuka;
Atagi, Shinji

Publication type:

Article

Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy.

Published in:

Investigational New Drugs, 2017, v. 35, n. 2, p. 217, doi. 10.1007/s10637-017-0435-2

By:

Tambo, Yuichi;
Hosomi, Yukio;
Sakai, Hiroshi;
Nogami, Naoyuki;
Atagi, Shinji;
Sasaki, Yasutsuna;
Kato, Terufumi;
Takahashi, Toshiaki;
Seto, Takashi;
Maemondo, Makoto;
Nokihara, Hiroshi;
Koyama, Ryo;
Nakagawa, Kazuhiko;
Kawaguchi, Tomoya;
Okamura, Yuta;
Nakamura, Osamu;
Nishio, Makoto;
Tamura, Tomohide

Publication type:

Article

Phase I dose-escalation study evaluating safety, tolerability and pharmacokinetics of MEDI-573, a dual IGF-I/II neutralizing antibody, in Japanese patients with advanced solid tumours.

Published in:

Investigational New Drugs, 2015, v. 33, n. 1, p. 194, doi. 10.1007/s10637-014-0170-x

By:

Iguchi, Haruo;
Nishina, Tomohiro;
Nogami, Naoyuki;
Kozuki, Toshiyuki;
Yamagiwa, Yumiko;
Yagawa, Katsuro

Publication type:

Article